Regulatory and Quality Solutions LLC Acquires Maetrics
Regulatory and Quality Solutions LLC (R&Q), a provider of regulatory and quality consulting services for medical devices, in vitro diagnostic devices (IVDs), and combination products, has announced that it has acquired Maetrics LLC.
“We are thrilled to be part of R&Q,” said Maetrics President, Steve Cottrell. “Together, we provide a truly unique consultancy offering to the life science industry. With our combined capabilities, clients know they are working with a partner that they can trust to deliver. The healthcare sector is so important to our everyday lives—now more than ever—and both R&Q and Maetrics are dedicated to continually supporting this mission with our effective regulatory and quality solutions.”
R&Q and Maetrics offer specialist consultancy services like to the medical device, diagnostics, and pharmaceutical industries.
Read more about those services in the full release, here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
HHS Cancels Moderna Grant for Late-Stage Development of mRNA Vaccine Candidate
June 4th 2025Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s award for almost $600 million to accelerate vaccine development will be terminated.
